These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19779315)

  • 1. Screening the postmenopausal ovary.
    Nachtigall LE
    Menopause; 2009; 16(6):1092. PubMed ID: 19779315
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovarian status in healthy postmenopausal women.
    Healy DL; Bell R; Robertson DM; Jobling T; Oehler MK; Edwards A; Shekleton P; Oldham J; Piessens S; Teoh M; Mamers P; Taylor N; Walker F
    Menopause; 2008; 15(6):1109-14. PubMed ID: 18536617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian status in healthy postmenopausal women: follow-up 12 months after transvaginal ultrasound.
    Bell RJ; Healy DL; Robertson DM; Jobling T; Oehler MK; Edwards A; Shekleton P; Oldham J; Piessens S; Teoh M; Mamers P; Taylor N; Walker F
    Menopause; 2009; 16(6):1149-55. PubMed ID: 19574938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer screening.
    van Nagell JR; Pavlik EJ
    Clin Obstet Gynecol; 2012 Mar; 55(1):43-51. PubMed ID: 22343228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is it possible to have organized screening for ovarian cancer?].
    Navone R; Montanari G
    Pathologica; 2003 Apr; 95(2):67-70. PubMed ID: 12768874
    [No Abstract]   [Full Text] [Related]  

  • 6. Whither the simple ovarian cyst in postmenopausal women?
    Parsons A
    Ultrasound Obstet Gynecol; 2002 Aug; 20(2):112-6. PubMed ID: 12153659
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced ovarian cancer detection. Two-test combo may identify disease early enough to cure it.
    Duke Med Health News; 2009 Jun; 15(6):8-9. PubMed ID: 19575525
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical practice. Screening for ovarian cancer.
    Clarke-Pearson DL
    N Engl J Med; 2009 Jul; 361(2):170-7. PubMed ID: 19587342
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for ovarian cancer: a pilot randomised controlled trial.
    Jacobs IJ; Skates SJ; MacDonald N; Menon U; Rosenthal AN; Davies AP; Woolas R; Jeyarajah AR; Sibley K; Lowe DG; Oram DH
    Lancet; 1999 Apr; 353(9160):1207-10. PubMed ID: 10217079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of adnexal masses in postmenopausal women.
    van Nagell JR; DePriest PD
    Am J Obstet Gynecol; 2005 Jul; 193(1):30-5. PubMed ID: 16021055
    [No Abstract]   [Full Text] [Related]  

  • 11. Reproducibility in the assessment of postmenopausal ovaries with transvaginal ultrasound.
    Modugno F; Weissfeld JL; Hill LM
    Gynecol Oncol; 2000 May; 77(2):289-92. PubMed ID: 10785480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of sonographic measurement of ovarian volume to diagnosing ovarian tumors in postmenopausal women.
    Bruchim I; Aviram R; Halevy RS; Beyth Y; Tepper R
    J Clin Ultrasound; 2004; 32(3):107-14. PubMed ID: 14994250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: factors affecting visualization of postmenopausal ovaries: descriptive study from the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Ludovisi M; Mavrelos D; Jurkovic D
    Ultrasound Obstet Gynecol; 2014 May; 43(5):600. PubMed ID: 24789306
    [No Abstract]   [Full Text] [Related]  

  • 14. Imaging and Screening of Ovarian Cancer.
    Lowry KP; Lee SI
    Radiol Clin North Am; 2017 Nov; 55(6):1251-1259. PubMed ID: 28991564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing ovarian cancer.
    Walker M; Sobel M
    CMAJ; 2018 Oct; 190(42):E1259. PubMed ID: 30348741
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary on 'Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening'.
    Wan Y; Crosbie E
    BJOG; 2014 Dec; 121 Suppl 7():40-7. PubMed ID: 25488087
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.
    Menon U; Talaat A; Jeyarajah AR; Rosenthal AN; MacDonald ND; Skates SJ; Sibley K; Oram DH; Jacobs IJ
    Br J Cancer; 1999 Jul; 80(10):1644-7. PubMed ID: 10408412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific keynote: ovarian cancer risk assessment and the potential for early detection.
    Urban N
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S75-9; discussion S80-3. PubMed ID: 12586091
    [No Abstract]   [Full Text] [Related]  

  • 19. Personalizing ovarian cancer screening.
    Goozner M
    J Natl Cancer Inst; 2010 Aug; 102(15):1112-3. PubMed ID: 20668268
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum CA 125 combined with transvaginal ultrasonography for ovarian cancer screening.
    Roupa Z; Faros E; Raftopoulos V; Tzavelas G; Kotrotsiou E; Sotiropoulou P; Karanikola E; Skifta E; Ardavanis A
    In Vivo; 2004; 18(6):831-6. PubMed ID: 15646829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.